Literature DB >> 22183501

Blood markers of alcohol use in epistaxis patients.

Michael B Soyka1, Thomas Schrepfer, David Holzmann.   

Abstract

Epistaxis and alcohol overconsumption are frequently encountered in patients admitted to emergency wards. The aim of the study was to analyze indirect markers of alcohol overconsumption in epistaxis patients and evaluate its role as a risk factor. In a cohort of 510 epistaxis patients indirect markers of alcohol overuse were measured including the mean corpuscular volume (MCV), gamma glutamyltransferase (GGT), aspartate aminotransferase and alanine aminotransferase. The results were compared to the normal findings in literature. Pathologic mean levels of GGT were found in epistaxis patients. Almost 5% had macrocytosis and MCV correlated positively with liver enzyme levels. Platelet counts were negatively correlated with both corpuscular volumes and liver enzymes. Indirect markers of alcohol overconsumption were found to be elevated in epistaxis patients. These results suggest that a subgroup of epistaxis patients overconsumes alcoholic beverages supporting the idea of alcohol abuse being a risk factor in epistaxis. Questioning about drinking habits should be employed and help offered to affected patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183501     DOI: 10.1007/s00405-011-1881-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  25 in total

Review 1.  Liver enzyme alteration: a guide for clinicians.

Authors:  Edoardo G Giannini; Roberto Testa; Vincenzo Savarino
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

2.  Macrocytosis--an Australian general practice perspective.

Authors:  Stella Elisabeth Rumsey; Bevan Hokin; Parker John Magin; Dimity Pond
Journal:  Aust Fam Physician       Date:  2007-07

Review 3.  [Current aspects in epistaxis].

Authors:  B J Folz; M Kanne; J A Werner
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

4.  [Epistaxis strategy--experiences with the last 360 hospitalizations].

Authors:  D Simmen; B Heinz
Journal:  Laryngorhinootologie       Date:  1998-02       Impact factor: 1.057

5.  [Causes of epistaxis in relation to season and weather status].

Authors:  R Stopa; R Schönweiler
Journal:  HNO       Date:  1989-05       Impact factor: 1.284

Review 6.  Identifying the alcoholic.

Authors:  S B Rosalki
Journal:  Contemp Issues Clin Biochem       Date:  1984

7.  Evaluation of macrocytosis by general practitioners.

Authors:  K Seppä; K Heinilä; P Sillanaukee; M Saarni
Journal:  J Stud Alcohol       Date:  1996-01

8.  Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients.

Authors:  Daniela Rinck; Helge Frieling; Anne Freitag; Thomas Hillemacher; Kristina Bayerlein; Johannes Kornhuber; Stefan Bleich
Journal:  Drug Alcohol Depend       Date:  2007-01-17       Impact factor: 4.492

9.  Macrocytosis as a consequence of alcohol abuse among patients in general practice.

Authors:  K Seppä; P Laippala; M Saarni
Journal:  Alcohol Clin Exp Res       Date:  1991-10       Impact factor: 3.455

10.  Alcohol use disorders in the emergency ward: choice of the best mode of assessment and identification of at-risk situations.

Authors:  Charlotte Richoux; Isabelle Ferrand; Enrique Casalino; Benoit Fleury; Christine Ginsburg; Michel Lejoyeux
Journal:  Int J Emerg Med       Date:  2011-06-14
View more
  2 in total

1.  The long-term fate of epistaxis patients with exposure to antithrombotic medication.

Authors:  Rafael R Stadler; Rahel Kindler; David Holzmann; Michael B Soyka
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-09       Impact factor: 2.503

2.  Analysis of mean platelet volume and red blood cell distribution width in recurrent epistaxis.

Authors:  Ali Ekber Karabulut; Yunsur Çevik; Emine Emektar; Şeref Kerem Çorbacioğlu; Seda Dağar; Oğuz Yardim
Journal:  Turk J Emerg Med       Date:  2018-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.